Physician profile
Patrick T Rucker
NPI 1114973013
$814.62
in general payments reported to CMS, 2019-2025
16 companies · $344 in 2025
The $344 reported for 2025 was more than what 75% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.98 · 2021: $79.69 · 2022: $16.88 · 2023: $78.30 · 2024: $261 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $182.30 | 2024-2025 | |
| Ge Healthcare | $128.03 | 2019-2024 | |
| Blue Earth Diagnostics | $120.02 | 2023-2025 | Posluma |
| Progenics Pharmaceuticals, INC. | $77.47 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $60.72 | 2024-2025 | Libtayo |
| Janssen Biotech, INC. | $36.97 | 2021-2025 | Rybrevant |
| Incyte Corporation | $32.50 | 2024 | Jakafi, Pemazyre, Monjuvi |
| Amgen INC. | $30.65 | 2021 | |
| Pharmaessentia USA Corporation | $24.04 | 2024 | Besremi |
| Agios Pharmaceuticals, INC. | $20.26 | 2025 | Pyrukynd |
| Merck Sharp & Dohme LLC | $19.75 | 2025 | Keytruda, Welireg |
| Takeda Pharmaceuticals U.S.A., INC. | $18.64 | 2025 | Fruzaqla |
| Cardinal Health 414 LLC | $18.32 | 2024 | |
| Aveo Pharmaceuticals, INC. | $17.28 | 2023 | Fotivda |
| Siemens Medical Solutions USA, INC. | $14.27 | 2024 | Biograph Mct X-4r |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Rucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.